Home › ZOSTAVAX (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product
 

Keywords :   


ZOSTAVAX (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product

2013-10-23 13:30:00| Merck.com - Product News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that ZOSTAVAX (Zoster Vaccine Live), the company's vaccine to help prevent shingles, received the Prix Galien USA 2013 Award for Best Biotechnology Product. Language: English Contact: Media:MerckCaroline Lappetito, (267) 305-7639 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: product usa live prix

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »